People diagnosed with type 2 diabetes might benefit soon from Eli Lilly's new orforglipron weight loss drug following its ...

Eli Lilly has seen positive results from a phase 3 trial of Orforglipron, the first-ever GLP-1 pill for weight loss and type ...

Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for ...

Living with diabetes doesn’t mean you can’t enjoy Easter treats and traditions. You might try food swaps or alternatives with ...

Eli Lilly reported promising results from a study of its experimental oral drug that could rival popular injections to treat ...

A new drug, called orforglipron, can help people with diabetes manage their A1C and weight, according to topline results from ...

The drug helped lower patients’ blood sugar and reduce their weight by an average of 16 pounds.

Drugmaker Eli Lilly said Thursday that an experimental pill form of popular GLP-1 medications helped people with type 2 ...

Two widely consumed food additive mixtures may increase type 2 diabetes incidence, according to a study published online April 8 in PLOS Medicine. Marie Payen de la Garanderie, from the Université ...

Eli Lilly said clinical results of its GLP-1 in pill form showed safety and efficacy data similar to blockbuster injectable ...

A new study, published in the journal PLOS Medicine, revealed that the combination of certain food additives can lead to an increased risk of dangerous health conditions, like type 2 diabetes.

A new study found that certain combinations of food additives are linked to a higher chance of developing type 2 diabetes. Experts discuss how to mitigate risk.